Pediatric oncologist Dr. Filemon Dela Cruz of MSK discusses how cutting-edge Tumor Sequencing and Bionformatics paired with AI modeling can help find druggable master regulators (chokepoints) in Ewing Sarcoma.
Ewing's U: Dr. Filemon Dela Cruz: A Systems Biology Approach to Identifying Targetable Vulnerabilities in Ewing Sarcoma
Previous
Previous
Ewing’s U: Dr. Matthew Ladra: Proton Radiation Therapy for Pediatric Sarcomas
Next
Next